semaglutide prediabetes progression to type 2 diabetes trial Reversion normoglycemia with tirzepatide vs in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5 | Journal of Endocrinological Investigation Two-year effects of semaglutide in

Common Side Effects Nausea, vomiting, diarrhea, constipation (very common, especially during dose escalation) Abdominal pain and decreased appetite Dyspepsia and eructation (belching) Injection site reactions Fatigue and dizziness Hair loss (reported in clinical trials) Hypersensitivity reactions Seek Immediate Medical Attention For Severe, persistent abdominal pain possibly radiating to the back (pancreatitis) Neck lump or swelling, hoarseness, difficulty swallowing or breathing Severe allergic reactions: swelling of face, lips, tongue, throat

Complete a Medical Review Your health history, medications, allergies and relevant safety considerations are reviewed before a plan is recommended

Physical Form Other, Other, Lyophilized Powder sterile, lyophilized powder Dosage Guidelines Reconstitute with bacteriostatic water before use

Type 2 diabetes approval could follow a separate timeline

"Palatin Technologies Announces Litigation Settlement With Competitive Technologies" (Press release)